(Q46830857)

25 December 2017

title

HIV-1 Tat raises an adjuvant-free humoral immune response controlled by its core region and its ability to form cysteine-mediated oligomers (English)

1 reference

25 December 2017

author name string

Jongrak Kittiworakarn

1

1 reference

25 December 2017

Alain Lecoq

2

1 reference

25 December 2017

Gervaise Moine

3

1 reference

25 December 2017

Robert Thai

4

1 reference

25 December 2017

Evelyne Lajeunesse

5

1 reference

25 December 2017

Pascal Drevet

6

1 reference

25 December 2017

Claude Vidaud

7

1 reference

25 December 2017

André Ménez

8

1 reference

25 December 2017

Michel Léonetti

9

1 reference

25 December 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

25 December 2017

Journal of Biological Chemistry

published in

1 reference

25 December 2017

volume

281

1 reference

25 December 2017

issue

6

1 reference

25 December 2017

page(s)

3105-3115

1 reference

25 December 2017

Antibody and cytokine responses in efferent lymph following vaccination with different adjuvants

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509899200

Immunological adjuvants: a role for liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509899200

Immunological concepts of vaccine adjuvant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509899200

The trans-activator gene of HTLV-III is essential for virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509899200

The trans-activator gene of the human T cell lymphotropic virus type III is required for replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509899200

HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509899200

Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509899200

The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509899200

Identification of a novel domain of HIV tat involved in monocyte chemotaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509899200

Native HIV-1 Tat protein targets monocyte-derived dendritic cells and enhances their maturation, function, and antigen-specific T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509899200

HIV-1 Tat reprograms immature dendritic cells to express chemoattractants for activated T cells and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509899200

Speed of progression to AIDS and degree of antibody response to accessory gene products of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509899200

Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509899200

Single-step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509899200

The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509899200

Pronounced acute immunosuppression in vivo mediated by HIV Tat challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509899200

Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509899200

Human immunodeficiency virus 1 Tat binds to dipeptidyl aminopeptidase IV (CD26): a possible mechanism for Tat's immunosuppressive activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509899200

The N-terminal structure of HIV-1 Tat is required for suppression of CD26-dependent T cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509899200

Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509899200

The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509899200

Identification of an Arg-Gly-Asp (RGD) cell adhesion site in human immunodeficiency virus type 1 transactivation protein, tat

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509899200

The carrier effect in the secondary response to hapten-protein conjugates. II. Cellular cooperation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509899200

Highly stable oligomerization forms of HIV-1 Tat detected by monoclonal antibodies and requirement of monomeric forms for the transactivating function on the HIV-1 LTR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509899200

Tat protein from human immunodeficiency virus forms a metal-linked dimer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509899200

Genetic tests to reveal TAT homodimer formation and select TAT homodimer inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509899200

Effects of HIV-1 Tat protein on human T cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509899200

Structure of a heparin-linked biologically active dimer of fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509899200

Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509899200

HIV-1 Tat protein mimicry of chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509899200

Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509899200

Migration of V delta 1 and V delta 2 T cells in response to CXCR3 and CXCR4 ligands in healthy donors and HIV-1-infected patients: competition by HIV-1 Tat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509899200

Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509899200

Identification of specific molecular structures of human immunodeficiency virus type 1 Tat relevant for its biological effects on vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509899200

The RGD-containing domain of exogenous HIV-1 Tat inhibits the engulfment of apoptotic bodies by dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509899200

Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509899200

Characterization of HIV-1 Tat proteins mutated in the transactivation domain for prophylactic and therapeutic application.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509899200

21 January 2018

Identifiers

DOI

10.1074/JBC.M509899200

1 reference

25 December 2017

PubMed ID

16321975

1 reference

25 December 2017